SCHEMBL13236377

SCHEMBL13236377

COC(=O)c1c(CO)cnc(C)c1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.53
ALDH1A1 P00352 7/20 0.53
HPGD P15428 4/20 0.53
HSD17B10 Q99714 1/20 0.53
LMNA P02545 5/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
AOX1 Q06278 1/20 0.51
TRIM24 O15164 1/20 0.50
TRIM33 Q9UPN9 1/20 0.50
PDXK O00764 1/20 0.47
HTT P42858 5/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
L3MBTL1 Q9Y468 3/20 0.42
GAA P10253 3/20 0.42
MAPT P10636 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
POLB P06746 1/20 0.42
THRB P10828 1/20 0.42
APEX1 P27695 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29388363 0.81 KDM4E (0.58) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL195230 0.81 KDM4E (0.58) KDM4EALDH1A1HPGDHSD17B10LMNA
Hydrochloric Acid SCHEMBL28265157 0.80 TRIM24 (0.57) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL5188886 0.80 KDM4E (0.56) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL1983313 0.80 KDM4E (0.60) KDM4EALDH1A1HPGDHSD17B10LMNA
Hydrochloric Acid SCHEMBL2164217 0.79 TRIM24 (0.55) KDM4EALDH1A1HPGDHSD17B10LMNA
Hydrochloric Acid SCHEMBL2164219 0.79 KDM4E (0.54) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL11623305 0.79 KDM4E (0.54) KDM4EALDH1A1HPGDHSD17B10LMNA
Potassium Ion SCHEMBL8725003 0.79 KDM4E (0.54) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL26054339 0.77 KDM4E (0.53) KDM4EALDH1A1HPGDHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216818-A1 Inhibitors of Post-Amadori Advanced Glycation End Products KHALIFAH RAJA 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216818-A1 Inhibitors of Post-Amadori Advanced Glycation End Products AGER, GLA, OGA KDM4E 2055/4885ALDH1A1 175/4885HPGD 1576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.